AssetMark Inc
PRAX icon

AssetMark Inc’s Praxis Precision Medicines PRAX Stock Holding History

AssetMark Inc’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$395K Buy
1,355
+1,354
+135,400% +$448K ﹤0.01% 1296
2026
Q2 		$335 Buy
+1
New +$317 ﹤0.01% 3359
2025
Q1 		– Sell
-7
Closed -$539 – 2736
2024
Q4 		$539 Buy
+7
New +$506 ﹤0.01% 2360

Other funds holding PRAX

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $106B AUM 32.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Candriam SCA
Candriam SCA Strassen, Luxembourg, Luxembourg $22.5B AUM 50.38% 1-Year Est. Return
SEB Asset Management
SEB Asset Management Stockholm $27B AUM
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Moody Aldrich Partners
Moody Aldrich Partners Marblehead, Massachusetts $523M AUM 75.24% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $179B AUM 16.96% 1-Year Est. Return
Mutual of America Capital Management
Mutual of America Capital Management New York $10.1B AUM 33.74% 1-Year Est. Return

AssetMark Inc's PRAX Position: Q3 2026 in Review

AssetMark Inc increased its Praxis Precision Medicines (PRAX) stake by 135,400% in Q3 2026, buying an estimated $448K and bringing the position to 1,355 shares worth $395K. The position accounts for ﹤0.01% of the portfolio, ranked #1296.

AssetMark Inc first reported a position in PRAX in Q4 2024 and has held it in 3 quarters since. 95 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • AssetMark Inc held 1,355 shares of Praxis Precision Medicines worth $395K as of Q3 2026.
  • AssetMark Inc bought 1,354 Praxis Precision Medicines shares in Q3 2026, an estimated $448K.
  • Praxis Precision Medicines made up ﹤0.01% of AssetMark Inc's portfolio in Q3 2026, its #1296 holding.
  • AssetMark Inc first reported a position in Praxis Precision Medicines in Q4 2024 and has held it in 3 quarters since.
  • 95 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on AssetMark Inc's 13F filing for Q3 2026, filed 21 Oct 2026.